Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionDFAU - Dimensional US Core Equity Market ETF
Latest Disclosed Ownership32,546 shares
Latest Disclosed Value $ 915,518
DFAU - Dimensional US Core Equity Market ETF reports 0.75% decrease in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On June 29, 2026 - DFAU - Dimensional US Core Equity Market ETF filed a NPORT-P form disclosing ownership of 32,546 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $915,519 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 32,792 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of -0.75% during the quarter. The current value of the position is $1,024,874 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-29 2026-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 32,546 -246 -0.75 916 14.95 0.0080
2026-03-27 2026-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 32,792 2,325 7.63 797 22.84 0.0075
2025-12-29 2025-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 30,467 9,996 48.83 648 48.62 0.0065
2025-09-25 2025-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 20,471 5,277 34.73 437 18.16 0.0050
2025-06-26 2025-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 15,194 -2,374 -13.51 369 -6.82 0.0050
2025-03-28 2025-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 17,568 -158 -0.89 396 2.59 0.0054
2024-12-30 2024-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 17,726 0 0.00 386 26.56 0.0059
2024-09-27 2024-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 17,726 0 0.00 306 14.66 0.0050
2024-06-26 2024-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 17,726 3,766 26.98 267 32.34 0.0051
2024-03-28 2024-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 13,960 248 1.81 201 18.24 0.0042
2023-12-28 2023-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 13,712 2,191 19.02 170 6.92 0.0044
2023-09-27 2023-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 11,521 2,373 25.94 159 9.66 0.0040
2023-06-26 2023-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 9,148 850 10.24 146 13.28 0.0044
2023-03-30 2023-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 8,298 180 2.22 129 14.29 0.0042
2022-12-27 2022-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 8,118 1,280 18.72 113 60.00 0.0044
2022-09-29 2022-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 6,838 3,766 122.59 70 204.35 0.0028
2022-06-27 2022-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 3,072 3,027 6,726.67 23 0.0012
2022-03-31 2022-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 45 0 0.00 0 0.0000
2021-12-29 2021-10-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 45 0 0.00 0 0.0000
2021-09-29 2021-07-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 45 0 0.00 0 0.0000
2021-06-24 2021-04-30 NP CATALYST PHARMACEUTICALS EC US14888U1016 45 0 0.00 0 -100.00 0.0000
2021-03-31 2021-01-31 NP CATALYST PHARMACEUTICALS EC US14888U1016 45 45 0 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.